Text this: Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: Post hoc analyses from the IPASS study

__    __    ______    ______    _____     _____   
\ \\ / //  /_   _//  /_____//  |  ___||  |__  //  
 \ \/ //    -| ||-   `____ `   | ||__      / //   
  \  //     _| ||_   /___//    | ||__     / //__  
   \//     /_____//  `__ `     |_____||  /_____|| 
    `      `-----`   /_//      `-----`   `-----`  
                     `-`